2024-01-25 04:45:00 ET
Summary
- Patient Capital Management are long-term, contrarian, value investors focusing on growing wealth through Time, not Timing. We operate with the singular purpose of serving clients and helping them enhance their long term investment returns.
- The strategy advanced 37.6% net of fees, nicely beating the S&P 500’s 26.3% return.
- We have further work to fully recoup 2022’s losses, but 2023’s recovery continues our track record of rebounding strongly after disappointing performance.
- While we expect the bull market to continue, returns aren’t likely to be as strong as 2023.
By Samantha McLemore
"The big money is not in the buying and selling, but in the waiting." Charlie Munger
Read the full article on Seeking Alpha
For further details see:
Patient Capital Management Opportunity Equity Strategy Q4 2023 Commentary